---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-022295"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:39:09.141934+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# ExoZymes files updated investor presentation for NCTx business; no specific financial data disclosed

## Summary
- eXoZymes issued an updated investor presentation dated November 13, 2025, focusing on its NCTx business.
- No new financial metrics, guidance, or operational milestones were included in the filing text.
- The presentation content was not appended; only the exhibit description was provided.
- Investors should review the full presentation for details, which is available as Exhibit 99.1.

## SEC filing metadata
- accession: 0001493152-25-022295
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000149315225022295/0001493152-25-022295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000149315225022295/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-022295
- JSON: https://secwatch.observer/filing/0001493152-25-022295.json
- Plain text: https://secwatch.observer/filing/0001493152-25-022295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.